These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 95450)

  • 21. [Effect of amphotericin B on the activity of synthetic polyribonucleotide interferon inducers].
    Vil'ner LM; Lashkevich VA
    Vopr Virusol; 1982; 27(2):166-9. PubMed ID: 6178217
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Does anesthesia depress the immune response in the surgical patient?
    Micheels J
    Acta Anaesthesiol Belg; 1977; 28(4):277-89. PubMed ID: 613707
    [No Abstract]   [Full Text] [Related]  

  • 23. Interferons: rationale for clinical trials in neoplastic disease.
    Borden EC
    Ann Intern Med; 1979 Sep; 91(3):472-9. PubMed ID: 382941
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recent advances in the study of interferon.
    Ho M
    Pharmacol Rev; 1982 Mar; 34(1):119-29. PubMed ID: 6175986
    [No Abstract]   [Full Text] [Related]  

  • 25. [Interferon and its implication for malignant brain tumor].
    Shitara N; Takakura K; Sano K
    No Shinkei Geka; 1979 Jul; 7(7):645-52. PubMed ID: 471175
    [No Abstract]   [Full Text] [Related]  

  • 26. [Prevention of 5-FU induced toxicity in C3 H/HE mice with interferon or with interferon inducers (poly 1: C, OK-432, Lentinan)].
    Akimoto M; Ueki H; Nakajima Y; Matano S; Ewasaki H; Abe R; Kasai M
    Gan To Kagaku Ryoho; 1984 Jul; 11(7):1462-7. PubMed ID: 6204597
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interferon inducing activity of polyinosinic acid.
    De Clercq E; Stollar BD; Thang MN
    J Gen Virol; 1978 Jul; 40(1):203-12. PubMed ID: 99486
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potentiation of interferon action.
    Schwarz LA; Fleischmann WR
    Tex Rep Biol Med; 1981-1982; 41():298-306. PubMed ID: 6184817
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Combined action of a specific vaccine, exogenous interferon and an interferon inducer on the development of acute experimental encephalomyelitis].
    Barinskiĭ IF; Vagabov RM
    Vopr Virusol; 1983; 28(1):62-6. PubMed ID: 6189299
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Host factors important in immune surveillance against tumours.
    Ada GL
    IARC Sci Publ; 1982; (39):223-39. PubMed ID: 6185418
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interferon induction and prostaglandin synthetase inhibition in the in vitro and in vivo manipulation of immune response expression in an animal model of bladder cancer.
    Droller MJ; Gomolka D
    Cell Immunol; 1982 Sep; 72(1):1-13. PubMed ID: 6184169
    [No Abstract]   [Full Text] [Related]  

  • 32. The interferon system as an integral part of the defense system against infections.
    Kirchner H
    Antiviral Res; 1986 Jan; 6(1):1-17. PubMed ID: 2421640
    [No Abstract]   [Full Text] [Related]  

  • 33. [Pharmacological and immunotherapeutic properties of levamisole (a review of the literature)].
    Sakharchuk II; Skakal'skaia LM
    Vrach Delo; 1982 Aug; (8):4-8. PubMed ID: 6983185
    [No Abstract]   [Full Text] [Related]  

  • 34. Interferons, a group of multiple lymphokines.
    Kirchner H
    Springer Semin Immunopathol; 1984; 7(4):347-74. PubMed ID: 6084313
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of interferon and lymphokines on lymphocytes.
    Gifford GE; Tobey M
    Tex Rep Biol Med; 1977; 35():375-80. PubMed ID: 358461
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Recommendations for evaluation of interferon inducers of clinical importance].
    Andzhaparidze OG; Bektemirov TA; Burgasova MP
    Vopr Virusol; 1978; (4):494-7. PubMed ID: 219621
    [No Abstract]   [Full Text] [Related]  

  • 37. [Innate nonspecific antiviral immunity].
    Błach-Olszewska Z
    Postepy Hig Med Dosw; 1999; 53(1):3-21. PubMed ID: 10352544
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aspects of immunobiology and immunotherapy and uses of monoclonal antibodies and biologic immune modifiers in human gliomas.
    Lee Y; Bigner DD
    Neurol Clin; 1985 Nov; 3(4):901-17. PubMed ID: 2417097
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interferon and cell-mediated immunity.
    Yabrov A
    Med Hypotheses; 1979 Jul; 5(7):769-97. PubMed ID: 390329
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Host defenses against viral disease.
    Merigan TC
    N Engl J Med; 1974 Feb; 290(6):323-9. PubMed ID: 4358448
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.